MeSH term
Frequency | Condition_Probility | Humans | 22 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Carcinoma, Hepatocellular/*genetics/metabolism/pathology | 2 | 20.0 |
Cytoskeletal Proteins/*genetics/metabolism | 2 | 9.0 |
DNA Mutational Analysis | 8 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Female | 9 | 0.0 |
Liver Neoplasms/*genetics/metabolism/pathology | 2 | 18.0 |
Loss of Heterozygosity | 5 | 0.0 |
Male | 6 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Mutation | 6 | 0.0 |
Proteins/*genetics | 4 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
*Repressor Proteins | 10 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
*Trans-Activators | 6 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
*Zebrafish Proteins | 8 | 3.0 |
Blotting, Northern | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Glycogen Synthase Kinase 3 | 3 | 3.0 |
Immunohistochemistry | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Adult | 6 | 0.0 |
Aged | 5 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Genes, APC | 2 | 2.0 |
Middle Aged | 8 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Proteins/genetics | 3 | 0.0 |
Adolescent | 4 | 0.0 |
Brain Neoplasms/*genetics | 3 | 2.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Infant | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 6 | 0.0 |
Base Sequence | 7 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Cytoskeletal Proteins/*genetics | 2 | 1.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Repressor Proteins/*genetics | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
